Abstract:Background and Objective The limited number of samples and high-dimensional features in microarray data make selecting a small number of features for disease diagnosis a challenging problem. Traditional feature selection methods based on evolutionary algorithms are difficult to search for the optimal set of features in a limited time when dealing with the high-dimensional feature selection problem. New solutions are proposed to solve the above problems. Methods In this paper, we propose a hybrid feature selection method (C-IFBPFE) for biomarker identification in microarray data, which combines clustering and improved binary particle swarm optimization while incorporating an embedded feature elimination strategy. Firstly, an adaptive redundant feature judgment method based on correlation clustering is proposed for feature screening to reduce the search space in the subsequent stage. Secondly, we propose an improved flipping probability-based binary particle swarm optimization (IFBPSO), better applicable to the binary particle swarm optimization problem. Finally, we also design a new feature elimination (FE) strategy embedded in the binary particle swarm optimization algorithm. This strategy gradually removes poorer features during iterations to reduce the number of features and improve accuracy. Results We compared C-IFBPFE with other published hybrid feature selection methods on eight public datasets and analyzed the impact of each improvement. The proposed method outperforms other current state-of-the-art feature selection methods in terms of accuracy, number of features, sensitivity, and specificity. The ablation study of this method validates the efficacy of each component, especially the proposed feature elimination strategy significantly improves the performance of the algorithm. Conclusions The hybrid feature selection method proposed in this paper helps address the issue of high-dimensional microarray data with few samples. It can select a small subset of features and achieve high classification accuracy on microarray datasets. Additionally, independent validation of the selected features shows that those chosen by C-IFBPFE have strong correlations with disease phenotypes and can identify important biomarkers from data related to biomedical problems.

An efficient approach for identifying important biomarkers for biomedical diagnosis

Controlled variable selection with nonconvex regularization for identifying biomarkers

Identifying High-Dimensional Biomarkers for Personalized Medicine via Variable Importance Ranking

A Linear Programming Model for Identifying Non-Redundant Biomarkers Based on Gene Expression Profiles

Statistical Methods for Selective Biomarker Testing

Machine Learning Driven Biomarker Selection for Medical Diagnosis

A Flexible Approach for Predictive Biomarker Discovery

Selecting Biomarkers for building optimal treatment selection rules using Kernel Machines

Detecting Biomarkers for Major Adverse Cardiac Events Using SVM with PLS Feature Selection and Extraction.

An improved binary particle swarm optimization algorithm for clinical cancer biomarker identification in microarray data

Identifying network biomarkers based on protein-protein interactions and expression data

biosigner: A New Method for the Discovery of Significant Molecular Signatures from Omics Data

A novel method to guide biomarker combinations to optimize the sensitivity

Logistic regression analysis with standardized markers

Logistic regression and other statistical tools in diagnostic biomarker studies

15N tracer techniques for the differential diagnosis of dwarfism and prediction of growth hormone action in children.

Variable selection in high-dimensional logistic regression models using a whitening approach

Network-based logistic regression integration method for biomarker identification

Coupling bootstrap with synergy self-organizing map-based orthogonal partial least squares discriminant analysis: Stable metabolic biomarker selection for inherited metabolic diseases

On the Optimal Combination of Elliptically Distributed Biomarkers to Improve Diagnostic Accuracy

Efficient screening of predictive biomarkers for individual treatment selection